Julianne Gee

8.5k citations

74 papers · 4.6k indexed · 6 hit papers · h-index 32

Co-authors: Tanya R. Myers Lauri E. Markowitz Tom T. Shimabukuro John R. Su Paige Marquez Eric Weintraub David K. Shay Shannon Stokley
Topics: Vaccine Coverage and Hesitancy (39 papers)SARS-CoV-2 and COVID-19 Research (32 papers)Cervical Cancer and HPV Research (17 papers)
Cited by: Health Infectious Diseases Obstetrics and Gynecology
Journals: JAMA PEDIATRICS Clinical Infectious Diseases
Partner nations: United States Uganda Kenya

In The Last Decade

Julianne Gee

73 papers receiving 4.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020

2020 521 citations Matthew F. Daley, Julianne Gee et al. MMWR Morbidity and Mortality Weekly Report profile →
Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States.

2014 447 citations Shannon Stokley, Jenny Jeyarajah et al. PubMed profile →
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021

2021 371 citations John R. Su, Julianne Gee et al. MMWR Morbidity and Mortality Weekly Report profile →
First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021

2021 275 citations Julianne Gee, Paige Marquez et al. MMWR Morbidity and Mortality Weekly Report profile →
Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines

2021 229 citations Johanna Chapin-Bardales, Julianne Gee et al. profile →
Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe

2022 116 citations Julianne Gee, Paige Marquez et al. profile →

Peers

Countries citing papers authored by Julianne Gee

Since Specialization

Citations

This map shows the geographic impact of Julianne Gee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julianne Gee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julianne Gee more than expected).

Fields of papers citing papers by Julianne Gee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julianne Gee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julianne Gee. The network helps show where Julianne Gee may publish in the future.

Co-authorship network of co-authors of Julianne Gee

This figure shows the co-authorship network connecting the top 25 collaborators of Julianne Gee. A scholar is included among the top collaborators of Julianne Gee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julianne Gee. Julianne Gee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Planning for the future of maternal immunization: Building on lessons learned from the COVID-19 pandemic 2024 ·Vaccine ·Dana Meaney‐Delman,(unknown),Kara N.D. Polen,Tara C. Jatlaoui,Sarah Meyer,Sara E. Oliver,Julianne Gee,Tom T. Shimabukuro,Hilda Razzaghi,Laura E. Riley,Romeo R. Galang,Van T. Tong,Suzanne M. Gilboa,Sascha Ellington,Amanda Cohn	3
2	A Texting- and Internet-Based Self-Reporting System for Enhanced Vaccine Safety Surveillance With Insights From a Large Integrated Health Care System in the United States: Prospective Cohort Study 2024 ·JMIR mhealth and uhealth ·Deborah E. Malden,Julianne Gee,Sungching Glenn,(unknown),Denison S Ryan,Zheng Gu,(unknown),(unknown),Amelia Jazwa,Michael M. McNeil,Eric Weintraub,Sara Y. Tartof	0
3	Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021–February 2022 2023 ·Vaccine ·Emily Jane Woo,Julianne Gee,Paige Marquez,James Baggs,Winston E. Abara,Michael M. McNeil,Rositsa B. Dimova,John R. Su	8
4	Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5–11 Years — United States, October 12–January 1, 2023 2023 ·MMWR Morbidity and Mortality Weekly Report ·Anne M. Hause,Paige Marquez,Bicheng Zhang,John R. Su,Tanya R. Myers,Julianne Gee,S. Panchanathan,Deborah Thompson,Tom T. Shimabukuro,David K. Shay	23
5	Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States 2023 ·JAMA Network Open ·Winston E. Abara,Julianne Gee,Paige Marquez,(unknown),Tanya R. Myers,(unknown),Jane Baumblatt,Emily Jane Woo,Deborah Thompson,Narayan Nair,John R. Su,Tom T. Shimabukuro,David K. Shay	41
6	Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults 2022 ·Vaccine ·Lindsay K. Tompkins,James Baggs,Tanya R. Myers,Julianne Gee,Paige Marquez,(unknown),D. J. Peake,(unknown),Anne M. Hause,Penelope Strid,Winston E. Abara,(unknown),Tom T. Shimabukuro,David K. Shay	2
7	A decade of data: Adolescent vaccination in the vaccine safety datalink, 2007 through 2016 2022 ·Vaccine ·Stephanie A. Irving,Holly C. Groom,(unknown),Matthew F. Daley,James G. Donahue,Julianne Gee,Rulin C. Hechter,Lisa A. Jackson,Nicola P. Klein,Elizabeth Liles,Tanya R. Myers,Shannon Stokley	1
8	Reactions following Pfizer-BioNTech COVID-19 mRNA vaccination and related healthcare encounters among 7,077 children aged 5-11 years within an integrated healthcare system 2022 ·Vaccine ·Deborah E. Malden,Julianne Gee,Sungching Glenn,Zhuoxin Li,Cheryl Mercado,Oluwaseye Ayoola Ogun,(unknown),Bruno Lewin,Bradley K. Ackerson,Amelia Jazwa,Eric Weintraub,Michael M. McNeil,Sara Y. Tartof	4
9	Novel vaccine safety issues and areas that would benefit from further research 2021 ·BMJ Global Health ·Daniel A. Salmon,P H Lambert,Hanna Nohynek,Julianne Gee,Umesh D. Parashar,Jacqueline E. Tate,Annelies Wilder‐Smith,Kenneth Hartigan‐Go,Peter G. Smith,Patrick Zuber	8
10	Expected Rates of Select Adverse Events After Immunization for Coronavirus Disease 2019 Vaccine Safety Monitoring 2021 ·The Journal of Infectious Diseases ·Winston E. Abara,Julianne Gee,Mark Delorey,Tun Ye,Yi Mu,David K. Shay,Tom T. Shimabukuro	7
11	Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system 2021 ·Vaccine ·Johanna Chapin-Bardales,Tanya R. Myers,Julianne Gee,David K. Shay,Paige Marquez,James Baggs,Bicheng Zhang,Charles Licata,Tom T. Shimabukuro	10
12	Long term risk of developing type 1 diabetes after HPV vaccination in males and females 2019 ·Vaccine ·Nicola P. Klein,Kristin Goddard,Edwin Lewis,(unknown),Julianne Gee,Frank DeStefano,Roger Baxter	11
13	Risk of Guillain-Barré Syndrome following quadrivalent human papillomavirus vaccine in the Vaccine Safety Datalink 2017 ·Vaccine ·Julianne Gee,Lakshmi Sukumaran,Eric Weintraub	18
14	Case-centered Analysis of Optic Neuritis After Vaccines: Table 1. 2016 ·Clinical Infectious Diseases ·Roger Baxter,Edwin Lewis,Bruce Fireman,Frank DeStefano,Julianne Gee,Nicola P. Klein	24
15	Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States.breakdown → 2014 ·PubMed ·Shannon Stokley,Jenny Jeyarajah,David Yankey,Maria Cano,Julianne Gee,(unknown),C. Robinette Curtis,Lauri E. Markowitz	447
16	Vaccination coverage levels among children enrolled in the Vaccine Safety Datalink 2013 ·Vaccine ·Natalie McCarthy,Stephanie A. Irving,James G. Donahue,Eric Weintraub,Julianne Gee,Edward A. Belongia,James Baggs	17
17	Mortality Rates and Cause-of-Death Patterns in a Vaccinated Population 2013 ·American Journal of Preventive Medicine ·Natalie McCarthy,Eric Weintraub,Claudia Vellozzi,Jonathan Duffy,Julianne Gee,James G. Donahue,Michael L. Jackson,Grace M. Lee,Jason M. Glanz,Roger Baxter,Marlene M. Lugg,Allison L. Naleway,Saad B. Omer,Cynthia Nakasato,Gabriela Vazquez‐Benitez,Frank DeStefano	21
18	Reported Adverse Events in Young Women Following Quadrivalent Human Papillomavirus Vaccination 2012 ·Journal of Women s Health ·Allison L. Naleway,Rachel Gold,(unknown),Karen Riedlinger,Michelle L. Henninger,Julianne Gee	22
19	Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink 2011 ·Vaccine ·Julianne Gee,Allison L. Naleway,Irene M. Shui,James Baggs,Ruihua Yin,Rong Li,Martin Kulldorff,Edwin Lewis,Bruce Fireman,Matthew F. Daley,Nicola P. Klein,Eric Weintraub	170
20	Incidence of Neonatal Herpes Simplex Virus Infections in Two Managed Care Organizations: Implications for Surveillance 2008 ·Sexually Transmitted Diseases ·Fujie Xu,Julianne Gee,Allison L. Naleway,Kenneth M. Zangwill,Bradley K. Ackerson,Eileen Eriksen,Eric Weintraub,Kathleen Hutchins,Feifei Wei,Stuart M. Berman,Lauri E. Markowitz	12

About Julianne Gee

Julianne Gee is a scholar working on Health, Infectious Diseases and Toxicology, having authored 74 papers that have together received 4.6k indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (39 papers), SARS-CoV-2 and COVID-19 Research (32 papers) and Cervical Cancer and HPV Research (17 papers). The work is most often cited by research in Health (1.9k citations), Infectious Diseases (1.9k citations) and Obstetrics and Gynecology (452 citations). Julianne Gee has collaborated with scholars based in United States, Uganda and Kenya. Frequent co-authors include Tanya R. Myers, Lauri E. Markowitz, Tom T. Shimabukuro, John R. Su, Paige Marquez, Eric Weintraub, David K. Shay, Shannon Stokley, Allison L. Naleway and James Baggs. Their work appears in journals such as JAMA, PEDIATRICS and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact